Insider Trading Activity CytomX Therapeutics Inc (NASDAQ:CTMX) – Director Sold 3,819 shares of Stock

ME Staff
-
0

Insider Trading Activity For CytomX Therapeutics Inc (NASDAQ:CTMX)

Frederick W Gluck , Director of CytomX Therapeutics Inc (NASDAQ:CTMX) reportedly Sold 3,819 shares of the company’s stock at an average price of 30 for a total transaction amount of $114,570.00 SEC Form

Insider Trading History For CytomX Therapeutics Inc (NASDAQ:CTMX)

  • On 10/14/2015 James E Flynn, Insider, bought 625,000 with an average share price of $12.00 per share and the total transaction amounting to $7,500,000.00.
  • On 10/14/2015 Frederick W Gluck, Director, bought 15,000 with an average share price of $12.00 per share and the total transaction amounting to $180,000.00.
  • On 10/14/2015 Cynthia J Ladd, VP, bought 3,000 with an average share price of $12.00 per share and the total transaction amounting to $36,000.00.
  • On 5/20/2016 Ix L.P. Canaan, Director, sold 8,687 with an average share price of $10.10 per share and the total transaction amounting to $87,738.70.
  • On 5/24/2016 Ix L.P. Canaan, Director, sold 13,253 with an average share price of $10.09 per share and the total transaction amounting to $133,722.77.
  • On 5/26/2016 Timothy M Shannon, Director, sold 51,343 with an average share price of $10.34 per share and the total transaction amounting to $530,886.62.
  • On 5/27/2016 Ix L.P. Canaan, Director, sold 25,082 with an average share price of $10.60 per share and the total transaction amounting to $265,869.20.

    • Analyst Ratings History For CytomX Therapeutics Inc (NASDAQ:CTMX)

    • On 3/20/2017 Instinet Boost Price Target of rating Sell with a price target of $21.00 to $32.00
    • On 5/8/2017 HC Wainwright Reiterated Rating Buy
    • On 8/8/2017 Cann Reiterated Rating Hold
    • On 8/25/2017 Jefferies Group Set Price Target of rating Buy with a price target of $25.00
    • On 10/4/2017 Wedbush Set Price Target of rating Buy with a price target of $26.00 to $37.00
    • On 10/4/2017 Nomura Boost Price Target of rating Buy with a price target of $44.00
    • On 10/4/2017 Bank of America Boost Price Target of rating Buy with a price target of $30.00 to $34.00

    Recent Trading Activity for CytomX Therapeutics Inc (NASDAQ:CTMX)
    Shares of CytomX Therapeutics Inc closed the previous trading session at 30.87 up +1.11 3.73% with 29.68000030517578 shares trading hands.